Company ProfilePremium

Balkrishna Paper Mills Limited

Company Profile Analysis

Tickers: BALKRISHNA.NS, 539251.BO

ESOMAR 23 Corporate BadgeISO Certifications Badge
Balkrishna Paper Mills Limited - Company showcase

Year Founded & Workforce

2013

Balkrishna Paper Mills Limited logo

Balkrishna Paper Mills Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Balkrishna Paper Mills Limited Overview

Note on founding year.

  • The CRISIL "incorporated 1961" and Screener "1975" dates most plausibly describe the legacy paper-board operation at Ambivali, which was historically part of the Balkrishna group (Balkrishna Industries Limited).

  • They do not describe the current legal entity. That entity was incorporated in June 2013 and received the paper-board undertaking on 10 February 2015 under a court-sanctioned scheme of arrangement.

Balkrishna Paper Mills Limited is a Mumbai-headquartered micro-cap belonging to the Siyaram–Poddar business group. It was carved out of Balkrishna Industries in 2015 to house the group's coated duplex and triplex paperboard manufacturing at Ambivali, Maharashtra. For most of its listed life the company made recycled-fibre packaging board for FMCG, pharmaceutical, garment, food and matchbox customers. Its scale was modest (peak revenue about ₹242 Cr in FY2022) and losses were chronic. In November 2024 the board ruled that Ambivali manufacturing was unviable, and the plant was classified as a discontinued operation. Today BPML is effectively a shell in transition. It generates under ₹5 Cr a year from trading paper and paperboard, carries roughly ₹166 Cr of borrowings and preference-share liabilities, and reports a negative net worth of ₹175 Cr. It depends on promoter-group inter-corporate deposits. Its forward thesis rests on three things: a capital-reduction scheme, monetising Ambivali assets, and a newly approved entry into real estate development.


What the company does today

BPML's operating activity in FY2026 consisted almost entirely of trading in paper and paperboard.

  • Revenue from operations was ₹473.22 lakh (₹4.73 Cr) in FY2026.

  • Purchases of stock-in-trade were ₹440.26 lakh, so the company earned a thin trading spread of about 7% before overheads (FY2026 audited results, NSE iXBRL, 22 May 2026).

  • The second reportable segment, Trading of plastic & packaging materials, recorded nil revenue in both FY2025 and FY2026.

The former core business, Manufacturing of Paper and Paper Board at Ambivali, is reported as a discontinued operation under Ind AS 105. The board decided to discontinue it at its meeting on 13 November 2024.

  • The board's stated reasons were heavy and persistent losses from high production costs, low productivity, low business volumes and high fixed costs (S&P Capital IQ via MarketScreener, 13 Nov 2024).

  • The FY2025 Directors' Report adds that an external consultant concluded Ambivali manufacturing was not viable. The consultant pointed to evolving market conditions, rising competition and changing consumer preferences toward digital alternatives (Directors' Report FY2025, via IIFL).

  • The same summary notes that the Ambivali plant and machinery had become obsolete (IIFL company summary).

Company's own description

The latest filings describe the business narrowly. In the going-concern note to the FY2026 results:

  • The company says it is engaged in trading paper and paperboard.

  • It says it is "confident to improve the paper and paper board business in the ensuing period."

  • It says it can explore other available resources to generate future cash flow (FY2026 audited results, Note 3).

The company's older self-description emphasised packaging board serving pharmaceuticals, cosmetics, healthcare products, readymade garments, food products, matchboxes and, mainly, FMCG customers (MarketsMojo / IIFL company profile). Screener's synthesis, drawn from a CRISIL rationale and the FY2025 annual report, says:

  • BPML formerly made coated duplex/triplex board from recycled wastepaper and pulp at Ambivali.

  • It now trades sustainable plastic and packaging materials and paper and paperboard.

  • It is examining new lines of business to make better use of its existing resources.

Business model and revenue model

DimensionCharacterisation (FY2026)
Revenue model100% product trading (resale of paper and paperboard). No service, subscription or licensing revenue.
Value-chain positionDistributor/trader between mills and packaging converters; formerly an integrated recycled-fibre board manufacturer
Customer typesB2B: packaging converters, printers, carton makers (historically FMCG, pharma, garments, food, matchbox end-users)
End-marketsIndian domestic packaging. Exports were material until FY2023 (₹58 Cr) and nil from FY2024.
Asset intensityNear zero operating assets. Property, plant and equipment was ₹37.43 lakh at 31 March 2026, against ₹1,526.81 lakh of assets held for sale (Ambivali disposal group).
Funding modelPromoter-group inter-corporate deposits (ICDs) and preference capital. No bank debt since CRISIL withdrew its rating in October 2024 on receipt of the lender's no-dues certificate.

Independent characterisation

Analytically, BPML is no longer a paper company in any economic sense. It is a financially distressed listed shell with three characteristics:

  1. A sub-scale trading activity that cannot cover finance costs. FY2026 finance costs of ₹607.95 lakh were 1.28× revenue.

  2. A disposal group of residual Ambivali assets, including machinery under a ₹13.62 Cr sale agreement.

  3. A promoter group that keeps funding it through ICDs while restructuring its capital.

The equity's value rests on three questions:

  • Can the NCLT-sanctioned capital reduction clean up the balance sheet?

  • Can land or other "available resources" (a phrase management repeats) be monetised, likely through the newly approved real estate development activity?

  • Will the promoter group keep subordinating its claims?

The trading turnover is a going-concern signal rather than a value driver.

Strategy

Stated strategy (themes from latest filings)

Management's stated strategy, distilled from the FY2025 Directors' Report, the FY2026 going-concern note and 2026 board outcomes, has three pillars:

  1. Grow paper and paperboard trading. The company highlights its "rich experience" in the paper and paperboard business. It cites FY2026 turnover of ₹473.22 lakh against ₹232.36 lakh in FY2025 as "significant growth" (FY2026 results Note 3).

  2. Monetise existing resources. Management refers repeatedly to "various other resources that can be put to optimum utilisation for generating future cash flows" (Q3 FY2026 Note 3), which in practice means the Ambivali assets.

  3. Diversify into new businesses. The Object Clause was altered in December 2023. In April 2026 the board approved entry into real estate development and allied activities.

Initiatives register (last 24 months)

DateInitiativeDetailTargets / financial parametersStatus
Apr–May 2024Rights issue and preference redemption₹45.11 Cr raised at ₹21/share; ₹25 Cr 9% CRPS redeemedDeleveragingCompleted
Oct 2024Exit from bank borrowingCRISIL rating withdrawn on banker's no-dues certificateBank debt eliminatedCompleted
13 Nov 2024Discontinue Ambivali manufacturingInd AS 105 discontinued operationStop operating lossesCompleted
13 Feb 2025 → Mar 2026Disposal of Ambivali machinerySale to Symcom Exim Pvt Ltd (unrelated party) at ₹13,61,80,000 + GST; advance ₹2,72,36,000 received 12 Mar 2026₹13.62 Cr inflowIn progress. Assets held for sale were ₹15.27 Cr at 31 Mar 2026.
23 Dec 2025Scheme of Reduction of Share CapitalEquity FV ₹10→₹1 across 3,22,19,532 shares; accumulated losses set off first against Securities Premium (₹23.29 Cr), then against equity capital (₹28.10 Cr per scheme figures). ₹110 Cr preference capital cancelled; consideration treated as an unsecured, non-interest-bearing loan until funds permit.Accumulated losses reduced from ₹278.39 Cr to ₹226.11 CrApproved by preference holders (19 Jun 2026) and equity holders (postal ballot 2 Jul 2026). Exchanges issued "return letters" on the scheme application (22 Apr 2026). NCLT sanction pending; current status of exchange no-objection not confirmed.
10 Apr 2026Entry into real estate developmentResidential and commercial development and allied activities; strategic focus on land monetisationInvestment "to be determined"Approved; no project disclosed
10 Apr 2026Related-party ICD facilitiesUp to ₹25 Cr each from S P Finance & Trading Ltd and Sanchna Trading & Finance Ltd in FY2027 and again in FY2028 (₹100 Cr aggregate headroom); up to 12% p.a.; unsecured; 1-year tenor, extendableFunds working capital, debt repayment and real-estate businessShareholder approval obtained 2 Jul 2026
FY2026Investment-property transactions₹180 lakh purchase, ₹50 lakh sale of investment property—Executed

Sustainability and ESG commitments: none disclosed.

Cost programmes: no formal programme with targets. Operating cost has fallen as a by-product of closing the mill.

Management medium-term targets and guidance

Not publicly disclosed. The company does not issue financial guidance, holds no earnings calls and publishes no investor presentations, per the retrieved exchange filings.

Products & Services

Current portfolio (FY2026–FY2027)

SegmentOfferingDescriptionTarget customerStatusPricing model
Paper & Paper Board (trading)Traded paper and paperboardResale of paper and board sourced from third-party mills. FY2026 purchases ₹440.26 lakh against sales ₹473.22 lakh.Packaging converters, printersActive; FY2026 revenue ₹473.22 lakhTransactional spot sales; not disclosed
Trading of plastic & packaging"Sustainable" plastic and packaging materialsTrading of plastic and packaging inputsPackaging usersDormant; nil revenue FY2025–FY2026. Segment assets were ₹35 lakh at Mar 2025 and nil at Mar 2026.—
Real estate (proposed)Residential and commercial development and allied activitiesBoard-approved 10 Apr 2026 under sub-clause 3 of Clause III(A) of the Memorandum. Investment size to be decided on project feasibility.Property buyers / lesseesPre-revenue; no project announced—

Legacy manufactured portfolio (discontinued November 2024)

Product (legacy brand)DescriptionTypical end-use
Eco Board (HWC)Coated duplex board, grey back (HWC grade)FMCG cartons, matchboxes
Eco–White Board (HWC)Coated board, white-top variantConsumer packaging
Eco Kraft Back Board (HWC)Coated board with kraft backHeavier cartons
Duplex Coated Board (DCB)Standard coated duplex boardPharma, FMCG, garments
Super Chromo Board (White Back)Premium coated board, white back (triplex-type)Cosmetics, premium FMCG
Super Chromo Board (White Back–Premium)Premium grade of the aboveHigh-end printing and packaging
Super Chromo Board (White Shade)White-shade premium gradePremium packaging

MarketScreener's business description lists the product range made at Ambivali from recycled wastepaper and pulp. All of these products were discontinued in FY2025.

Specifications (GSM range, brightness, bulk), launch years and pricing for these grades are not publicly disclosed in retrieved sources. Ambivali's installed capacity is also not disclosed in retrieved sources.

Financial Narrative

Data basis and caveats

  • Figures are standalone, in ₹ Cr, from Screener.in (C-MOTS data) and cross-checked to the FY2026 audited results (NSE iXBRL, 22 May 2026) and FY2025 audited figures (Q3 FY2026 filing).

  • FY2024 onward is on a continuing-operations basis for revenue and operating lines. Net profit includes discontinued operations.

  • FY2022 and FY2023 include the then-operating Ambivali mill.

  • These differences make year-on-year comparisons across FY2023 to FY2024 structurally discontinuous.

Income statement (₹ Cr)

Sources: Screener.in standalone P&L; gross profit from StockAnalysis (₹ million converted to ₹ Cr); EBIT is analyst-derived (operating profit less depreciation).

Margin profile (%)

Analyst calculations. EBITDA margin as reported by Screener (OPM). Net margins in FY2024–FY2026 are dominated by exceptional and discontinued items and finance costs on a tiny revenue base, so they carry little analytical signal.

Revenue CAGR.

  • FY2022→FY2026 4-year revenue CAGR: –62.6% (analyst calculation).

  • Screener reports 5-year sales CAGR of –48% and 3-year of –65%.

FY2026 detailed P&L (₹ lakh, audited)

Source: FY2026 audited results iXBRL, NSE, 22 May 2026. The FY2026 discontinued pre-tax loss of ₹135.04 lakh became a ₹36.96 lakh profit after a ₹172.00 lakh tax credit.

Anatomy of the FY2025 "profit" (₹ lakh)

Source: Q3 FY2026 results, Note 5 (FY2025 audited column): The FY2025 net profit of ₹818.65 lakh was therefore an accounting outcome:

  • Excluding exceptional items, the loss before tax was ₹876.43 lakh.

  • The largest component was the reversal of previously accrued preference dividends, which is non-cash.

  • In Q3 FY2026 a further ₹193.27 lakh exceptional gain came from "sundry credit balances written back".

Balance sheet (₹ Cr, 31 March)

Sources: Screener.in balance sheet; cash from StockAnalysis; FY2026 confirmed to audited Statement of Assets & Liabilities (net worth –₹17,544.16 lakh). FY2025 net worth –₹16,892.83 lakh per the Mar 2026 Reg 30 disclosure. Net debt is analyst-derived. FY2026 intangibles ₹3.06 lakh.

Debt composition at 31 March 2026 (₹ lakh, audited).

Debt composition — analyst interpretation (not company-confirmed).

  • Current borrowings of ₹2,355 lakh reconcile exactly to the two related-party ICDs outstanding at year-end: S P Finance & Trading Ltd ₹1,800 lakh and Sanchna Trading & Finance Ltd ₹555 lakh (H2 FY2026 RPT disclosure).

  • Non-current borrowings of ₹14,250 lakh very likely include the ₹11,000 lakh of 6.5% non-cumulative redeemable preference shares, classified as a financial liability under Ind AS 32. The balance (about ₹3,250 lakh) is not itemised in retrieved sources.

Working capital and liquidity (31 March 2026).

  • Current assets: ₹217.96 lakh. Current liabilities: ₹2,681.52 lakh.

  • Working capital: –₹2,463.56 lakh (–₹24.6 Cr).

  • Current ratio: 0.08×. Including assets held for sale and associated liabilities, it is about 0.52×.

  • Cash, bank and current investments totalled ₹170.51 lakh.

Cash flow (₹ Cr)

Source: Screener.in. Screener's "free cash flow" appears to net asset-disposal proceeds against operating cash flow, so it is not a pure CFO-minus-capex measure.

  • Net cash used in operating activities was ₹156.60 lakh (–₹1.57 Cr), not –₹4.29 Cr.

  • Investing inflow was ₹5.36 lakh, comprising PPE sale proceeds ₹134.37 lakh, investment-property sale ₹50.00 lakh, investment-property purchase –₹180.00 lakh, and interest received ₹2.17 lakh.

  • Financing inflow was ₹88.40 lakh: borrowings raised ₹3,500 lakh, repaid ₹2,895 lakh, and other outflows (likely interest) ₹515.27 lakh.

  • Cash fell from ₹82.23 lakh to ₹19.39 lakh.

Capex was nil in FY2026 (purchase of PPE ₹0).

FY2026 investment property. The FY2026 statement shows a ₹180 lakh purchase of investment property and a ₹50 lakh sale. This is the first cash footprint of real-estate activity, preceding the April 2026 formal board approval to enter real estate.

Ratio analysis

Analyst calculations, plus Screener for days ratios. Screener leaves ROCE blank for FY2025 and FY2026; zero values in the table mean "not reported", not 0%.

Ratios that are not meaningful.

ROE and debt/equity: are not meaningful because shareholders' equity has been negative in every year shown.

ROIC: turns not meaningful from FY2024 because invested capital (equity plus debt) became negative: –₹6.68 Cr in FY2024, –₹8.89 Cr in FY2025 and –₹9.35 Cr in FY2026. Earlier ROIC was –11.1% in FY2022 and –56.4% in FY2023.

Net debt/EBITDA: is not meaningful (negative EBITDA in all years).

Recent quarterly trajectory (₹ Cr)

Source: Screener.in quarterly standalone. Q1 FY2027 is the quarter ended 30 June 2026. Q2 FY2027 results were pending at the cut-off; the trading window has been closed since 1 October 2026.

Commentary on trends, inflections and drivers

1. FY2022–FY2023: the manufacturing collapse.

  • FY2022 revenue peaked at ₹242 Cr, of which exports were ₹114.65 Cr (MarketScreener geographic data). That year still showed an operating loss of ₹5.6 Cr. The reported net loss was held to ₹4.7 Cr only by a ₹13.55 Cr gain on sale of immovable property.

  • FY2023 revenue halved and the operating loss widened to ₹35 Cr.

  • The drivers cited by management are consistent: high cost of production, low productivity, high fixed costs, and a market moving toward integrated, virgin-fibre and larger recycled-board producers.

2. FY2024: write-downs.

  • Fixed assets fell from ₹120.88 Cr to ₹26.81 Cr.

  • Other income of –₹62.91 Cr shows impairments and losses on assets.

  • The net loss peaked at ₹71.14 Cr and net worth troughed at –₹221.88 Cr.

3. FY2025: a balance-sheet event, not an operating recovery.

  • The ₹45.11 Cr rights issue lifted equity capital to ₹32.22 Cr and funded the redemption of ₹25 Cr of 9% preference shares.

  • That redemption allowed ₹14.95 Cr of accrued preference dividend to be written back. Together with a ₹9.10 Cr asset-sale gain, this produced a ₹8.19 Cr reported profit.

  • Borrowings fell by ₹55 Cr.

4. FY2026: steady-state cash burn.

  • With manufacturing gone, the structural run-rate is clear: revenue of about ₹4–5 Cr, EBITDA of about –₹0.9 Cr, and finance cost of about ₹6 Cr.

  • The result is a recurring pre-tax loss of ₹6.5–7 Cr a year, funded by promoter ICDs.

5. The key inflection ahead is capital structure, not operations.

  • If the NCLT sanctions the scheme, ₹110 Cr of preference capital becomes a non-interest-bearing unsecured loan. This could cut reported finance costs materially, assuming much of the current finance cost is imputed on the preference liability (analyst inference).

  • Equity capital would shrink to ₹3.22 Cr, and accumulated losses would fall from ₹278.39 Cr to ₹226.11 Cr (scheme figures, 30 Sep 2025 basis).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment revenue (INR Lakh)

Segment revenue (INR Lakh)FY2025FY2026

Paper and Paper Board trading (continuing)

232.36473.22

Trading of plastic and packaging materials (continuing)

00

Ambivali manufacturing (discontinued)

54.640

Gross value of sales incl. discontinued

287.00473.22

Segment EBIT (INR Lakh)

Segment EBIT (INR Lakh)FY2025FY2026

Paper and Paper Board trading (continuing)

-78.80-80.64

Ambivali manufacturing (discontinued)

-211.94-135.04

Total segment EBIT

-290.74-215.68

Finance costs

585.69607.95

Segment Margins & Growth (%) and Revenue by Segment (%)

MetricFY2025FY2026

Paper trading segment EBIT margin (%)

-33.9-17.0

Paper trading revenue YoY growth (%)

—103.7

Paper trading share of continuing revenue (%)

100100

Paper trading share of gross sales incl. discontinued (%)

81.0100

Segment Overview

SegmentAssetsLiabilities (as filed)

Paper and Paper Board

258.631,142.23

Trading of plastic & packaging

0.000.00

Ambivali (discontinued, held for sale)

1,526.81643.21

Total

1,785.44

1,785.44 (as filed; total liabilities on the balance sheet are ₹19,329.60 lakh)

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Revenue (INR Cr)

242.38109.303.432.324.73

Total expenses excl. D&A and interest (INR Cr)

247.97144.374.393.165.62

Gross profit (INR Cr)

84.0630.090.040.160.33

Operating profit / EBITDA (INR Cr)

-5.59-35.07-0.96-0.84-0.89

Other income incl. exceptional (INR Cr)

15.760.15-62.9114.920.48

Interest / finance cost (INR Cr)

8.5010.997.215.886.09

Depreciation (INR Cr)

6.176.120.060.020.01

EBIT (INR Cr)

-11.76-41.19-1.02-0.86-0.90

Pre-tax income (INR Cr)

-4.50-52.03-71.148.18-6.51

Net income (INR Cr)

-4.69-51.88-71.148.19-6.52

EPS basic (INR)

-1.46-16.11-22.082.54-2.02

EPS diluted (INR)

-1.46-16.11-22.082.54-2.02

Dividend per share (INR)

00000

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Gross margin (%)

34.727.51.26.97.0

EBITDA margin (%)

-2.31-32.09-27.99-36.21-18.82

Operating (EBIT) margin (%)

-4.9-37.7-29.7-37.1-19.0

Net margin (%)

-1.9-47.5-2,074.0353.0-137.8

Income Statement

Line item (INR Lakh)Q4 FY2026FY2026

Revenue from operations

88.96473.22

Other income

6.3010.80

Purchases of stock-in-trade

82.36440.26

Employee benefit expense

15.4155.61

Finance costs

192.71607.95

Depreciation and amortisation

0.321.42

Other expenses

18.6567.36

Profit before tax, continuing

-214.19-688.58

Profit after tax, discontinued

-61.5536.96

Net profit, total

-275.74-651.62

Total comprehensive income

-275.31-651.35

Exceptional Item Details

Exceptional item (INR Lakh)FY2025

Profit on sale/discard of fixed assets / impairment on assets held for sale

910.14

Provision for preference dividend written back

1,494.86

Amortisation of preference-share issue expenses

-92.59

Inventory written off

-617.33

Total exceptional gain (net)

1,695.08

Balance Sheet

MetricFY2022FY2023FY2024FY2025FY2026

Total assets (INR Cr)

187.04134.8045.3318.9217.85

Fixed assets net (INR Cr)

127.73120.8826.810.420.40

Cash and short-term investments (INR Cr)

0.060.440.430.821.71

Total borrowings (INR Cr)

204.74223.53215.20160.04166.09

Net debt (INR Cr)

204.68223.09214.77159.22164.38

Equity share capital (INR Cr)

10.7410.7410.7432.2232.22

Reserves / other equity (INR Cr)

-109.25-161.20-232.62-201.15-207.66

Net worth (INR Cr)

-98.51-150.46-221.88-168.93-175.44

Goodwill and intangibles (INR Cr)

00000.03

Components

ComponentAmount

Borrowings, current

2,355.00

Borrowings, non-current

14,250.00

Other non-current financial liabilities

1,750.00

Liabilities in disposal group held for sale

643.21

Trade payables

50.14

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Cash from operating activities (INR Cr)

-54.54-19.56-8.40-4.14-4.29

Cash from investing activities (INR Cr)

18.532.1411.9123.892.78

Cash from financing activities (INR Cr)

4.7817.79-3.53-19.350.88

Net cash flow (INR Cr)

-31.230.38-0.010.40-0.63

Free cash flow as computed by Screener (INR Cr)

-36.03-17.523.9719.39-0.22

Dividends paid (INR Cr)

00000

Buybacks (INR Cr)

00000

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2022FY2023FY2024FY2025FY2026

ROA (%)

-2.5-38.5-156.943.3-36.5

Interest coverage, EBIT/interest (x)

-1.38-3.75-0.14-0.15-0.15

Asset turnover (x)

1.300.810.080.120.26

Net debt / revenue (x)

0.842.0462.668.634.8

Debtor days

9.052.97188.3578.6616.21

Inventory days

93.8238.44690.160.000.00

Cash conversion cycle (days)

6.82-37.1376.3878.6616.21

ROCE as reported by Screener (%)

-9.38-45.86-3.0100

Income Statement (Quarterly)

MetricQ2FY25Q3FY25Q4FY25Q1FY26Q2FY26Q3FY26Q4FY26Q1FY27

Sales (INR Cr)

0.000.651.671.121.021.710.891.76

Operating profit (INR Cr)

-0.27-0.19-0.17-0.16-0.19-0.29-0.26-0.15

Interest (INR Cr)

1.561.251.221.251.161.741.931.30

Net profit (INR Cr)

-3.11-1.816.96-1.76-1.78-0.21-2.76-1.80

Region revenue (INR Cr)

Region revenue (INR Cr)FY2021FY2022FY2023FY2024FY2025

India

71.00127.7251.005.582.32

Export

56.00114.6558.0000

Total

127.00242.37109.005.582.32

Region YoY growth (%)

Region YoY growth (%)FY2022FY2023FY2024FY2025

India

79.9-60.1-89.1-58.4

Export

104.7-49.4-100.00

Valuation Snapshot

MetricValueSource / date

Last price (INR)

About 15.60

ScanX, around 20 Oct 2026

Market cap (INR Cr)

About 50

Analyst (32.22 M shares × ₹15.60); Screener ₹49.1 Cr at ₹15.9 (9 Oct 2026)

52-week high / low (INR)

24.3 / 11.3

Screener, Oct 2026

Beta

About 0.54–0.70

Sharpely; Equentis

Analyst coverage

0 analysts

Simply Wall St

Return metric (%)

Return metric (%)1 Year3 Year CAGR5 Year CAGR10 Year CAGR

Share price return (%)

-34-60-14

Valuation Multiples

MultipleBPMLPeer context

P/E (TTM)

Not meaningful (TTM loss ₹6.55 Cr)

JK Paper about 23× (Fyers, 2026 snapshot; column alignment uncertain)

P/B

Negative (about –0.3×; book value about –₹54 per share)

Peers positive

EV (INR Cr)

About 215 (₹50 Cr market cap + ₹164 Cr net debt incl. preference liability)

—

EV/Sales (TTM)

About 40× (TTM revenue ₹5.38 Cr)

Simply Wall St cited P/S 14.9× vs Indian packaging industry average 0.7× (Dec 2025)

EV/EBITDA

Not meaningful (negative EBITDA)

—

Capital return (INR per share)

Capital return (INR per share)FY2022FY2023FY2024FY2025FY2026

Dividend per share (INR)

00000

Credit Ratings

AgencyRatingOutlookDate

CRISIL

CRISIL BB / CRISIL A4+ (bank facilities)

Stable

Reaffirmed 29 Jan 2021 and 13 Apr 2022

CRISIL

Information-availability update

—

21 Jun 2023, 12 Jul 2023

CRISIL

Withdrawn at company request on lender no-dues certificate

—

18 Oct 2024

Moody's / S&P / Fitch

Not rated

——

Bucket Details

BucketAmountComposition

Within 12 months

2,355.00

Related-party ICDs (S P Finance ₹1,800; Sanchna ₹555); 1-year tenor, extendable

Beyond 12 months

14,250.00

Primarily the ₹11,000 lakh 6.5% non-cumulative redeemable preference shares (analyst inference) plus other non-current borrowings

Other non-current financial liabilities

1,750.00

Not itemised

Total

18,355.00—

Analyst Conclusions

Management guidance and consensus

Management guidance: none quantitative. Qualitatively, management expects to improve the paper and paperboard trading business and to use "other available resources" for cash flow (FY2026 Note 3). The board has approved a real estate development business (April 2026).

Consensus: none. No sell-side coverage exists.

Bull case

  1. Capital structure reset. NCLT sanction would cancel ₹110 Cr of preference capital (converted to a non-interest-bearing loan) and remove ₹52 Cr of accumulated losses. This could materially reduce reported finance costs, currently ₹6.08 Cr a year, and narrow losses toward the operating run-rate of about –₹0.9 Cr.

  2. Land monetisation through real estate. If BPML retains developable Ambivali land in the Mumbai Metropolitan Region periphery, a joint development or outright development could create value well above the roughly ₹50 Cr market cap. The ₹180 lakh investment-property purchase in FY2026 shows real-estate activity has begun.

  3. Sustained promoter support. ₹100 Cr of approved ICD headroom, a no-pledge stance and 59.95% promoter ownership indicate the group is unlikely to let the listed entity fail.

Bear case

  1. Value accrues to creditors and promoters, not minorities. Liabilities of ₹193 Cr dwarf assets of ₹17.85 Cr. Any monetisation proceeds first service related-party ICDs and the deferred preference loan, both largely promoter-linked, leaving residual equity value uncertain.

  2. Structural losses and going-concern doubt. Every year shows negative EBITDA. Finance costs exceed revenue. The auditor's qualification is repetitive, and Q1 FY2027 shows no improvement (loss ₹1.80 Cr).

  3. Execution risk on every lever. The exchanges returned the scheme application in April 2026. The machinery sale was undelivered at FY2026 year-end. The real-estate business has no projects, staff or disclosed land bank.

Catalysts and monitorables (next 12 months)

Catalyst / monitorableExpected timingWhy it matters
Q2 FY2027 resultsOct–Nov 2026Finance cost and trading run-rate
Exchange no-objection and NCLT filing/sanction of the capital-reduction schemeFY2027 (timing undisclosed)Balance-sheet reset
Completion of the Symcom Exim machinery sale (₹10.9 Cr balance)OverdueCash inflow; derecognition of held-for-sale assets
Disclosure of land title and real-estate projectUndatedCore of equity thesis
ICD drawdowns under the FY2027 limitsOngoingMeasures promoter support and cash burn
Any change in auditor opinionFY2027 audit (May 2027)Going-concern signal
Cyber incident follow-upUndatedPotential data-exposure liabilities

Analyst verdict

Balkrishna Paper Mills is no longer an operating paper company. It is a restructuring situation wrapped in a listed shell.

  • The November 2024 closure of the Ambivali mill ended a decade of value destruction. In that decade, revenue fell from a peak of ₹242 Cr to under ₹5 Cr, and net worth deteriorated to –₹175 Cr.

  • What remains is a paper-trading activity earning a 7% gross spread on ₹4.7 Cr of sales. It sits beneath a ₹166 Cr stack of preference capital and promoter-group deposits, whose finance cost alone exceeds revenue.

  • The auditor's going-concern qualification is entirely warranted.

The equity's value therefore cannot be derived from earnings, cash flow or book value; all three are negative. It is an option on three contingent events:

  1. NCLT sanction of the capital-reduction scheme. This would neutralise the ₹110 Cr preference liability and much of the finance cost.

  2. Credible disclosure that BPML controls developable land. This would give substance to the April 2026 real-estate pivot.

  3. Continued subordination of claims by the Poddar group. The group has funded every gap so far.

The governance profile demands caution. The Chair and MD roles are combined, funding is wholly related-party at up to 12%, and disclosure is minimal: no guidance, no investor communications, and an annual report that is hard to access. With no institutional holders and no analyst coverage, price discovery is shallow.

At about ₹50 Cr, the market is already paying for a meaningful probability that restructuring and land monetisation succeed. That price is not a clear mispricing in either direction. Investors who assign high odds to promoter-led asset monetisation may see the option as reasonably priced. Fundamentals-driven investors should treat BPML as uninvestable until three things happen:

  • the scheme is sanctioned;

  • the land position is disclosed; and

  • a funded real-estate project with identifiable economics is announced.

Our stance is Avoid / speculative only. The next two disclosures that would change it are the NCLT outcome and the first real-estate project announcement.


SOURCES (primary filings first)

  1. NSE iXBRL Integrated Filing — FY2026 Audited Results, Balance Sheet, Cash Flow, RPT schedule (22 May 2026): nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_160452_22052026230251_iXBRL_WEB.html

  2. NSE — Q3/9M FY2026 Unaudited Results with Limited Review (7 Feb 2026): nsearchives.nseindia.com/corporate/BALKRISHNA_07022026173321_UAFRason31122025.pdf

  3. NSE iXBRL — Q2 FY2026 Results (14 Nov 2025): nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_128198_14112025185242_iXBRL_WEB.html

  4. NSE — Intimation of IT Security Incident (15 Nov 2025): nsearchives.nseindia.com/corporate/BALKRISHNA_15112025175923_IntimationofITSecurityincident.pdf

  5. NSE — Reg 30 Disposal of Ambivali machinery (14 Mar 2026): nsearchives.nseindia.com/corporate/BALKRISHNA_14032026161717_Reg30ofSEBILODR.pdf

  6. NSE — Newspaper publication of FY2026 results (25 May 2026); Postal Ballot Notice (29 May 2026); PBN newspaper cutting (1 Jun 2026)

  7. NSE/BSE — Rights issue filings (4 Jan 2024; 15 Mar 2024; 19 Apr 2024); CRPS redemption (9 May 2024); Board outcome 12 Jun 2023; Postal ballot results 14 Dec 2023

  8. NSE — FY2022 Audited Results (24 May 2022): nsearchives.nseindia.com/corporate/AFR31032022_24052022144606.pdf

  9. NSE — Promoter shareholding disclosure (8 Apr 2021)

  10. BSE — Rights Issue Composite Application Form (Mar 2024)

  11. CRISIL Ratings — BPML rationales (29 Jan 2021; 13 Apr 2022; 21 Jun 2023; 18 Oct 2024)

  12. Screener.in — BPML standalone financials, shareholding, announcements (accessed Oct 2026)

  13. StockAnalysis — BPML income statement and balance sheet (FY2022–FY2026)

  14. MarketScreener — Segment, geographic, governance and event data

  15. ScanX (Dhan) — Scheme of capital reduction (30 May and 20 Jun 2026); Real estate entry and ICDs (11 Apr 2026); Machinery disposal (14 Mar 2026); FY2026 loss (26 May 2026)

  16. IIFL (indiainfoline) — Company summary; Directors' Report FY2025; Auditors' Report

  17. Chittorgarh — Rights issue size and subscription data

  18. Fyers — Peer comparison (2026 snapshot)

  19. Simply Wall St; Kalkine; Value Research; ICICIdirect; Anand Rathi; 5paisa; Kotak Securities; Equentis; Sharpely; MarketsMOJO; TipRanks — market data

  20. S&P Capital IQ via MarketScreener — Discontinuation announcement (13 Nov 2024)

  21. Papermart — Machinery sale and CCI investigation reports

  22. Breachsense — Third-party breach listing (26 Nov 2025)

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleSinceBackground / notesCompensation

Anurag Pawankumar Poddar (DIN 00599143)

Chairman & Managing Director

11 Feb 2015

Promoter family (Siyaram–Poddar group). Aged about 45 per MarketScreener (age data date uncertain). Signs all results.

Not disclosed in retrieved RPT data; total pay not disclosed

Manish Omkarmal Malpani (DIN 00055430)

Whole-time Director & CFO

Director from Aug 2023; WTD & CFO from 9 Dec 2023. Reappointed for 9 Dec 2026–8 Dec 2029 (board 22 May 2026; AGM 18 Sep 2026).

Born 1979 per Kalkine

₹17.99 lakh remuneration for H2 FY2026 (Oct 2025–Mar 2026)

Omprakash Singh (FCS 4304)

Company Secretary, Compliance Officer and Legal Head

15 Oct 2015

Born 1960 per Kalkine

₹5.44 lakh for H2 FY2026

Board of Directors

DirectorCategoryNotesSitting fees H2 FY2026 (INR Lakh)

Anurag P. Poddar

Executive, Promoter (Chairman & MD)

Chair/CEO roles combined

—

Ankit Poddar

Promoter-group director. Category per latest disclosures not confirmed; earlier AGM notices show retirement by rotation.

Elected chairman of the 19 Jun 2026 preference shareholders' EGM

—

Manish O. Malpani

Executive (WTD & CFO)

See above

—

Dileep H. Shinde (DIN 00270687)

Independent; Audit Committee Chairman

Appointed around Aug 2021

1.15

Dr. Mangesh D. Teli (DIN 00218899)

Independent

Appointed 9 Dec 2023

1.18

Ashok Nathmal Garodia

Independent

—0.90
—

Non-Executive Non-Independent

Appointed via postal ballot, results 28 Mar 2025

—

“—” = not publicly disclosed.

Board & Management Changes

DateChangeContext

8 May 2023

Director exit

Board refresh preceding rights issue

9 Dec 2023

Previous CFO/director tenure ended; Malpani appointed WTD & CFO; Dr. Teli appointed ID

Pre-rights-issue governance refresh

28 Mar 2025

Woman Non-Executive director and an Independent Director appointed

Compliance with board-diversity norms

22 May 2026 / 18 Sep 2026

Malpani reappointment recommended / approved

Continuity through restructuring

Shareholding Trend

Shareholder category (%)Jun 2024Mar 2025Mar 2026Jun 2026

Promoter and promoter group

59.9559.9559.9559.95

FIIs

0.010.000.000.00

DIIs

0.000.030.030.03

Public

40.0440.0240.0340.01

Number of shareholders (count)

14,76715,51614,83614,565

Competitive Landscape

Peer Comparison FY2026

CompanySegment overlapMarket cap (INR Cr)Annual PAT (INR Cr)RevenuePositioning vs BPML

JK Paper Ltd

Packaging board (incl. Sirpur, Cepac), writing and printing

7,440266—

Integrated leader; >100× BPML's scale

West Coast Paper Mills

Writing and printing, packaging

4,337151—

Integrated, wood-based

Seshasayee Paper & Boards

Writing/printing, boards

1,48483—

Profitable mid-cap

Andhra Paper

Writing/printing, board

1,26019—

Large mill

Tamil Nadu Newsprint & Papers (TNPL)

Packaging board, writing/printing

1,069248—

State-owned, large board capacity

Pudumjee Paper Products

Specialty paper

90094—

Niche specialty

N R Agarwal Industries

Duplex board, newsprint (recycled)

84844—

Closest legacy peer: recycled duplex board in western India

Emami Paper Mills

Duplex board, newsprint

68161—

Recycled-fibre board peer

Kuantum Papers

Writing/printing (agro-based)

66342—

Regional

Satia Industries

Writing/printing (agro-based)

60941—

Regional

ITC (Paperboards & Specialty Papers division)

Virgin and recycled board

Part of ITC Ltd

Not separable

—

Dominant premium board player

Balkrishna Paper Mills

Paper/board trading

57-7

4.73 (FY2026)

Distressed micro-cap

Peer Comparison FY2026 — Market cap

MetricBPMLJK PaperWest Coast PaperSeshasayee Paper

Market cap (INR Cr)

577,4404,3371,484

Annual PAT (INR Cr)

-726615183

Revenue growth

+104% FY2026 (tiny base)

———

EBITDA margin

-18.8% FY2026

———

Company Snapshot

$0.5M

Revenue

$6M

Market Cap

2013

Founded

Mumbai, India

Headquarters

SWOT Analysis

Strengths

  • Promoter backing is demonstrated. Group entities extended ICDs: ₹23.55 Cr outstanding at March 2026, with ₹35 Cr drawn in FY2026. Up to ₹100 Cr of further ICD headroom is approved for FY2027–FY2028 (FY2026 cash-flow statement; April 2026 board outcome).
  • Bank debt has been eliminated. CRISIL withdrew its rating in October 2024 on the banker's no-dues certificate, so there are no external secured lenders who could force insolvency.
  • Equity raising has worked before. The April 2024 rights issue raised ₹45.11 Cr at ₹21 per share, subscribed 1.06× (Chittorgarh).
  • No pledging. No promoter encumbrance existed on the 59.95% stake as of 31 March 2026 (SAST disclosure).
  • A capital-reduction scheme has stakeholder buy-in. It has 100% preference-holder approval (19 June 2026) and equity-holder approval (2 July 2026).
  • Asset monetisation is in hand. There is a ₹13.62 Cr signed machinery sale with 20% advance received, plus ₹15.27 Cr of assets held for sale (March 2026 filings).

Weaknesses

  • Net worth is deeply negative. It was –₹175.44 Cr at 31 March 2026, against a market cap of about ₹50 Cr (FY2026 audited results).
  • Finance costs exceed revenue. FY2026 finance costs of ₹607.95 lakh were 1.28× revenue of ₹473.22 lakh.
  • Going-concern doubt is formally recorded. The auditor's qualified opinion on material going-concern uncertainty is classified as "repetitive" (FY2026 iXBRL).
  • Operations make losses at every level. EBITDA has been negative in all of the last five years: –₹0.89 Cr in FY2026 and –₹35.07 Cr in FY2023.
  • Liquidity is thin. The current ratio was 0.08× at March 2026 (current assets ₹217.96 lakh against current liabilities ₹2,681.52 lakh).
  • There is no disclosure infrastructure. The company publishes no guidance, presentations or earnings calls. CRISIL flagged information-availability risk in June 2023.

Opportunities

  • Balance-sheet clean-up through the scheme. It cancels ₹110 Cr of preference capital (converted to a non-interest-bearing loan) and writes off ₹52.28 Cr of accumulated losses against premium and capital.
  • Real estate on legacy land. Development under the April 2026 approval could unlock value if the company holds developable land at Ambivali (MMR periphery). Land title is undisclosed.
  • Growing trading turnover. It doubled year on year (FY2026 +103.7%), and Q1 FY2027 sales of ₹1.76 Cr were the best quarter since closure.
  • Possible non-operating gains. Further write-backs of stale liabilities (₹193.27 lakh in Q3 FY2026) and asset-sale gains could offset losses.
  • Use of the listed vehicle. The listed structure with about 14,600 shareholders could serve as a vehicle for injecting group assets or businesses. This is speculative and nothing has been announced.
  • Tax credit potential. Accumulated losses (₹278 Cr book at September 2025) could shelter future profits, subject to tax-law limitations; tax-loss balances are not disclosed.

Threats

  • Scheme execution risk. BSE and NSE issued return letters on the scheme application in April 2026, and NCLT sanction is not assured.
  • Related-party dependence and governance. Funding is entirely from promoter-group entities at up to 12%. The ICDs are unsecured with one-year tenors, which creates refinancing risk if group support wavers.
  • Delivery risk on the asset sale. The Symcom Exim transaction was expected to complete in March 2026, yet the assets remained held for sale at year-end.
  • Cyber exposure. The November 2025 incident affected IT assets, and a third-party site claims a NightSpire leak listing.
  • Real estate execution risk. The company has no track record, staff or capital in development, and the regulatory regime (RERA) adds compliance load.
  • Regulatory consequences of prolonged negative net worth. These include exchange surveillance measures and a persistent "Strong Sell" quantitative rating (MarketsMOJO, last updated 6 January 2026).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
29 May 2025FY2025 audited results. Net profit ₹818.65 lakh, driven by ₹1,695.08 lakh exceptional gains. Qualified audit opinion (going concern). MarketScreener event log; Q3 FY2026 filingAccounting profit; operating loss persists
Aug 2025 (around 13 Aug)Q1 FY2026 results: sales ₹1.12 Cr, net loss ₹1.76 Cr Screener; TipRanksRun-rate losses
Sep 2025FY2025 Directors' Report confirms consultant-driven closure of Ambivali. IIFL Directors' ReportStrategic confirmation
27 Sep 2025Trading window closure from 1 Oct 2025 announced TipRanksRoutine
10 Nov 2025Board meeting intimation for Q2 results ScreenerRoutine
14 Nov 2025Q2/H1 FY2026 results. Net loss ₹178.28 lakh in Q2. Auditor's review qualified; net worth –₹17,247.41 lakh. Screener; NSE iXBRLGoing-concern qualification persists
15 Nov 2025Cyber-security incident: some IT assets affected and isolated; operations said to be unaffected NSE filingCyber risk materialised
26 Nov 2025Third-party breach tracker lists bpml.in as a victim of threat actor "NightSpire"; leak size unknown BreachsensePotential data exposure.
23 Dec 2025Board approves Scheme of Reduction of Share Capital ("Other Restructuring" filing) BSE; ScanXCore balance-sheet restructuring
Jan 2026Shareholding for Dec 2025 quarter: promoters 59.95% unchanged ScreenerPromoter commitment stable
7 Feb 2026Q3 FY2026 results. Revenue ₹171.08 lakh (best quarter post-closure); exceptional gain ₹193.27 lakh (sundry credits written back); net loss ₹21.30 lakh. Qualified review; net worth –₹17,268.89 lakh. NSE filingTrading revenue rising
9 Feb 2026Q3 results published in Financial Express and Mumbai Lakshadeep Business Standard media filingRoutine
14 Mar 2026Reg 30 disclosure: Ambivali machinery sold to Symcom Exim for ₹13.62 Cr + GST; 20% advance received NSE filing; ScanXLiquidity event
10 Apr 2026Board approves real-estate entry and ₹50 Cr/yr ICD facilities; postal ballot notice dated 10 Apr 2026 ScanXStrategic pivot
17 Apr 2026Confirms non-applicability of SEBI Large Corporate (debt) framework ScanXRoutine
22 Apr 2026Receives "return letters" from BSE and NSE on the capital-reduction scheme application ScanXRegulatory friction on scheme; resubmission status not confirmed
18–19 May 2026Board meeting intimation; promoter declares no encumbrance for FY2026 ScanX; VogueStockGovernance hygiene
22 May 2026FY2026 audited results: revenue ₹473.22 lakh; net loss ₹651.62 lakh; net worth –₹17,544.16 lakh; qualified opinion (repetitive). Malpani reappointment recommended. NSE iXBRL; VogueStockConfirms structural loss
24–25 May 2026FY2026 results published in newspapers NSE filingRoutine
29 May – 1 Jun 2026Postal ballot notice dispatched (e-voting 3 Jun – 2 Jul 2026; cut-off 22 May 2026) NSE filingsScheme-linked RPT and ICD approvals sought
8 Jun 2026EGM notice hand-delivered to preference holders (shorter notice with consent) ScanXProcess
19 Jun 2026Preference shareholders' EGM approves capital reduction unanimously (1.10 Cr shares, 100%) ScanXKey scheme approval
1–2 Jul 2026Trading window closed from 1 Jul 2026 for Q1 FY2027 SharpelyRoutine
2 Jul 2026Postal ballot resolutions passed with requisite majority; scrutinizer P. Naithani & Associates VogueStock; Value ResearchEquity-holder approval
14 Jul 2026Regulation 74(5) certificate for June quarter SharpelyRoutine
Aug 2026Q1 FY2027 results: sales ₹1.76 Cr; net loss ₹1.80 Cr ScreenerLoss run-rate unchanged
29 Aug 2026Newspaper notice of 13th AGM Screener/BSERoutine
18 Sep 202613th AGM approves financial statements and five resolutions, including key reappointments BSE AGM outcomeGovernance continuity
22 Sep 2026Trading window closed from 1 Oct 2026 until 48 hours after Q2 FY2027 results Screener/BSEQ2 FY2027 results imminent
5 Oct 2026Reg 74(5) certificate for September quarter; no shares dematerialised Screener/BSERoutine

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Income Statement: Revenue & Gross Profit (FY2022–FY2026): Revenue fell from INR 2,423.8 Mn in FY2022 to INR 47.3 Mn in FY2026.
Balkrishna Paper Mills Limited — Income Statement: Revenue & Gross Profit (FY2022–FY2026)
Series (INR Mn)FY2022FY2023FY2024FY2025FY2026
Revenue2,423.81,09334.323.247.3
Gross profit840.6300.90.41.63.3

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.